You are here
Home 🌿 Medical Cannabis News 🌿 $500M lawsuit accuses cannabis retailers of distributing product with incorrect THC and CBD levels 🌿$500M lawsuit accuses cannabis retailers of distributing product with incorrect THC and CBD levels

A class-action lawsuit filed in Calgary against cannabis companies claims the THC and CBD levels in their medicinal and recreational cannabis products differed from what was represented on packaging.
According to the statement of claim filed at the Judicial Centre of Calgary on Tuesday, June 16, the companies allegedly sold cannabis products to Canadian consumers with drastically different THC (tetrahydrocannabinol) or CBD (cannabidiol) levels than advertised on the label.
The defendants named in the lawsuit are:
- Aurora Cannabis Inc.
- Aurora Cannabis Enterprises Inc.
- AuroraCo.
- Aleafiaco
- Aleafia Health Inc.
- Emblem Cannabis Corp.
- Hexo Corp.
- HexoCo
- Cronos Group Inc.
- Cronosco
- Tilray Canada Ltd.
- Organigram Holdings Inc.
- OrganigramCo
- MediPharm Labs Corp.
- MediPharmCo
The document indicates that THC and CBD levels were found to be significantly higher than indicated in some products while others may have had significantly lower levels as a result of absorption or degradation due to the use of plastic bottles.
The lawsuit is seeking $500 million in compensation for Canadians who purchased medicinal cannabis products between now and June 16, 2010 as well as Canadians who legally purchased cannabis for recreational purposes since Oct. 17, 2018.
Lisa Marie Langevin is named as the plaintiff representing the class-action. The Calgary woman claims to have purchased a cannabis oil from a northwest store in mid-February 2020 at the recommendation of a staff member.
Langevin says it was her first time trying cannabis and she did not feel any psychotropic effects after using the product four times and increasing the dosage, over the period of a month. She then consulted a friend of hers, a doctor, who also tried the product and felt nothing.
According to the statement of claim, the doctor arranged to have both the product and the plastic vial tested and it was determined that the product only had 46 per cent of the active THC level indicated on the vial's label.
The allegations outlined in the lawsuit have not been tried in court.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.